Publications by authors named "Amy L Hamilton"

Claim this Profile
C
Crohn's Disease Stricture Response to Treatment Assessed with Magnetic Resonance Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial.
Grace C Lovett, Julien D Schulberg, Amy L Hamilton, Emily K Wright, Tom R Sutherland

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Results of Drug Treatment for Crohn's Disease Strictures.
Grace C Lovett, Julien D Schulberg, Amy L Hamilton, Emily K Wright, Bronte A Holt

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program.
Gina L Trakman, Erin E Russell, Amy L Hamilton, Amy Wilson-O'Brien, Emily Thompson

Nutrients· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol.
Sasha R Fehily, Emily K Wright, Chamara Basnayake, Amy L Wilson-O'Brien, Annalise Stanley, Amy L Hamilton

BMJ Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated endoscopic dilation and needle-knife stricturotomy for Crohn's disease strictures.
Julien D Schulberg, Amy L Hamilton, Emily K Wright, Bronte A Holt, Tom R Sutherland

Gastrointest Endosc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease.
Jiaying Zheng, Qianru Sun, Mengjing Zhang, Chengyu Liu, Qi Su, Amy L Hamilton

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Ultrasound and MRI for Monitoring Therapeutic Response in Luminal Crohn's Disease: A Systematic Review.
Grace C Lovett, Julien D Schulberg, Amy L Hamilton, Helen E Wilding, Michael A Kamm

J Am Coll Radiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Elizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, Maria Chaparro, Paolo Gionchetti, Amy L Hamilton

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Elizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, Maria Chaparro, Paolo Gionchetti, Amy L Hamilton

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
Emily K Wright, Maria Chaparro, Paolo Gionchetti, Amy L Hamilton, Julien Schulberg

J Crohns Colitis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence.
Amy L Hamilton, Peter De Cruz, Emily K Wright, Thierry Dervieux, Anjali Jain

J Crohns Colitis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study.
Gina L Trakman, Winnie Y Y Lin, Amy L Hamilton, Amy L Wilson-O'Brien, Annalise Stanley

Nutrients· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study.
Joyce W Y Mak, Sun Yang, Annalise Stanley, Xiaoqing Lin, Mark Morrison, Amy L Hamilton

JGH Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
Peter De Cruz, Amy L Hamilton, Kathryn J Burrell, Alexandra Gorelik, Danny Liew

Inflamm Bowel Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial.
Julien D Schulberg, Emily K Wright, Bronte A Holt, Amy L Hamilton, Tom R Sutherland

Lancet Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet and gut microbiome in gastrointestinal disease.
Gina L Trakman, Sasha Fehily, Chamara Basnayake, Amy L Hamilton, Erin Russell

J Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review.
Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton

J Gastroenterol Hepatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luminal microbiota related to Crohn's disease recurrence after surgery.
Amy L Hamilton, Michael A Kamm, Peter De Cruz, Emily K Wright, Hai Feng

Gut Microbes· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.
Julien D Schulberg, Emily K Wright, Bronte A Holt, Tom R Sutherland, Simon J Hume, Amy L Hamilton

J Gastroenterol Hepatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Surveys to Estimate Food Additive Intake.
Gina L Trakman, Winnie Lin, Amy L Wilson-O'Brien, Annalise Stanley, Amy L Hamilton

Nutrients· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteus spp. as Putative Gastrointestinal Pathogens.
Amy L Hamilton, Michael A Kamm, Siew C Ng, Mark Morrison

Clin Microbiol Rev· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.
Emily K Wright, Michael A Kamm, Peter De Cruz, Amy L Hamilton, Fabiyola Selvaraj

J Crohns Colitis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serologic antibodies in relation to outcome in postoperative Crohn's disease.
Amy L Hamilton, Michael A Kamm, Peter De Cruz, Emily K Wright, Fabiyola Selvaraj

J Gastroenterol Hepatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial Factors Associated with Postoperative Crohn's Disease Recurrence.
Emily K Wright, Michael A Kamm, Josef Wagner, Shu-Mei Teo, Peter De Cruz, Amy L Hamilton

J Crohns Colitis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Crohn's disease post-operative care.
Emily K Wright, Michael A Kamm, Peter Dr Cruz, Amy L Hamilton, Kathryn J Ritchie

World J Gastroenterol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis